• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: RETRACTABLE TECHNOLOGIES, INC. VANISHPOINT®; SYRINGE, ANTISTICK

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

RETRACTABLE TECHNOLOGIES, INC. VANISHPOINT®; SYRINGE, ANTISTICK Back to Search Results
Model Number 10131
Health Effect - Clinical Code No Consequences Or Impact To Patient (2199)
Date of Event 12/12/2018
Type of Reportable Event Malfunction
Event or Problem Description
After medication was given and the plunger was pressed in as far as it could go, the needle did not auto-retract into the device.The patient or staff member were not harmed.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VANISHPOINT®
Common Device Name
SYRINGE, ANTISTICK
Manufacturer (Section D)
RETRACTABLE TECHNOLOGIES, INC.
511 lobo ln
little elm TX 75068
MDR Report Key8270271
Report Number8270271
Device Sequence Number10802761
Product Code MEG
UDI-Device Identifier00613703101303
UDI-Public(01)00613703101303
Combination Product (Y/N)N
Initial Reporter StateVA
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type User Facility
Initial Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date (Section B) 12/13/2018
Report Date (Section F) 12/13/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Model Number10131
Device Catalogue Number10131
Device Lot NumberUNKNOWN
Was Device Available for Evaluation? Yes
Was the Report Sent to FDA? Yes
Event Location Hospital
Date Report to Manufacturer01/23/2019
Initial Date Received by Manufacturer Not provided
Initial Report FDA Received Date01/23/2019
Patient Sequence Number1
Date Report Sent to FDA12/13/2018
-
-